Jonathan Wan

562 total citations
6 papers, 96 citations indexed

About

Jonathan Wan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Dermatology. According to data from OpenAlex, Jonathan Wan has authored 6 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 2 papers in Dermatology. Recurrent topics in Jonathan Wan's work include Lung Cancer Treatments and Mutations (3 papers), Management of metastatic bone disease (2 papers) and Central Venous Catheters and Hemodialysis (2 papers). Jonathan Wan is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Management of metastatic bone disease (2 papers) and Central Venous Catheters and Hemodialysis (2 papers). Jonathan Wan collaborates with scholars based in Canada and New Zealand. Jonathan Wan's co-authors include Andrea Bezjak, Jason Agulnik, Lorraine Portelance, Linda Ofiara, Khalil Sultanem, Vera Hirsh, Sergio Faria, V. Cohen, Luís Souhami and Joseph Longo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Jonathan Wan

5 papers receiving 90 citations

Peers

Jonathan Wan

EMS

PRM

IM

SURGE

ONCOL

Henk J. Baarslag Netherlands

Jorge del Toro‐Cervera Spain

Antonios Κouparanis Greece

Andrea Pisani Ceretti Italy

Rhian Davies United States

Jan Heil Germany

Natalie Kirilcuk United States

Christine Jurus France

A. Odurny United Kingdom

Nan Zun Teo Singapore

Henk J. Baarslag Netherlands

Jonathan Wan

49 ×1.1

EMS

31 ×0.7

PRM

99 ×2.8

IM

45 ×1.6

SURGE

13 ×0.6

ONCOL

Citations per year, relative to Jonathan Wan Jonathan Wan (= 1×) peers Henk J. Baarslag

Countries citing papers authored by Jonathan Wan

Since Specialization

Citations

This map shows the geographic impact of Jonathan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Wan more than expected).

Fields of papers citing papers by Jonathan Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Wan. The network helps show where Jonathan Wan may publish in the future.

Co-authorship network of co-authors of Jonathan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Wan. A scholar is included among the top collaborators of Jonathan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Wan. Jonathan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Murray, Louise, Joseph Longo, Jonathan Wan, et al.. (2017). Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study. Radiotherapy and Oncology. 124(1). 74–79. 6 indexed citations

2.

Tsao, Jonathan, John Radwan, Marisa Finlay, et al.. (2013). Use of electronic medical record queries to support clinical decision quality assurance.. Journal of Clinical Oncology. 31(31_suppl). 239–239.

3.

Brade, Anthony, et al.. (2011). Final results: A phase I study of sorafenib and palliative radiation in patients with malignancy in the thorax, abdomen, or pelvis.. Journal of Clinical Oncology. 29(15_suppl). e13602–e13602. 1 indexed citations

4.

Wan, Jonathan & Andrea Bezjak. (2010). Superior Vena Cava Syndrome. Hematology/Oncology Clinics of North America. 24(3). 501–513. 22 indexed citations

5.

Wan, Jonathan & Andrea Bezjak. (2009). Superior Vena Cava Syndrome. Emergency Medicine Clinics of North America. 27(2). 243–255. 51 indexed citations

6.

Wan, Jonathan, V. Cohen, Jason Agulnik, et al.. (2009). Unexpected High Lung Toxicity from Radiation Pneumonitis in a Phase I/II Trial of Concurrent Erlotinib with Limited Field Radiation for Intermediate Prognosis Patients with Stage III or Inoperable Stage IIB Non–small-cell Lung Cancer(NSCLC). International Journal of Radiation Oncology*Biology*Physics. 75(3). S110–S110. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact